Implantable graft to close a fistula
View Patent ↗An implantable graft, which may be inserted into a fistula tract to occlude the primary opening of the fistula, is provided. The graft may have a curved, generally conical shape with a trumpet-like head end that continuously tapers to a smaller tail end. The graft may be an integral unit made of a single material, such as a heterograft material. Methods of closing single and multiple fistulae are also provided.
1. A method of treating an anorectal fistula of a human patient, the anorectal fistula having a tract extending from a primary opening positioned in the anorectum at the dentate line to a secondary opening, wherein the secondary opening is positioned outside the anorectum in the perianal skin, the method comprising
inserting a plug from the anorectum into the primary opening of the tract so as to occlude said primary opening, wherein the plug comprises a taper between a first plug end and a second plug end, wherein the plug comprises bioremodelable material that promotes cellular invasion and ingrowth and reconstruction of host tissue within the plug, and wherein the bioremodelable material is selected from the group consisting of a cadaveric material from a human donor and a heterograft material from a non-human donor, and
positioning the plug in the tract whereby the bioremodelable material extends along the fistula tract from the primary opening to the secondary opening and promotes cellular invasion and ingrowth and reconstruction of host tissue within the plug.
2. The method of claim 1 , wherein the bioremodelable material comprises dermal collagen.
3. The method of claim 2 , wherein the bioremodelable material comprises submucosa.
4. The method of claim 1 , wherein the plug incorporates a drug.
5. The method of claim 1 , wherein the plug incorporates an antibiotic agent.
6. The method of claim 1 , wherein the bioremodelable material comprises an intact acellular sheet of dermal collagen or submucosa.
7. The method of claim 1 , wherein said inserting comprises pulling said plug through the primary opening towards the secondary opening whereby wedging the plug into the primary opening.
8. The method of claim 1 , further comprising securing an end of the plug adjacent the primary opening to tissue of the patient.
9. The method of claim 1 , further comprising cutting portions of the plug extending from at least one of the primary opening and the secondary opening of the fistula after placement of the plug in the fistula.
10. The method of claim 1 , wherein the anorectal fistula comprises two or more tracts leading from the primary opening and the second plug end comprises a first tail and a second tail, the inserting comprising placing the first tail into a first tract and inserting the second tail into a second tract.
11. A method for treating an anorectal fistula of a patient, the fistula having a tract extending from a primary opening positioned in the anorectum at the dentate line to a secondary opening, wherein the secondary opening is positioned outside the anorectum in the perianal skin, the method comprising:
inserting a plug into the primary opening of the fistula so as to occlude the primary opening, wherein the plug comprises a generally conical body having a first end with a first diameter and a second end with a second diameter that is smaller than the first diameter, wherein the plug comprises bioremodelable material selected from the group consisting of a cadaveric material from a human donor and a heterograft material from a non-human donor,
positioning the plug in the tract whereby the bioremodelable material extends along the fistula tract from the primary opening to the secondary opening of the fistula and promotes cellular invasion and ingrowth and reconstruction of host tissue within the plug; and
securing an end of the plug to tissue of the patient, wherein the end is adjacent the primary opening or secondary opening.
12. The method of claim 11 , wherein:
said implanting includes positioning the second end of the plug adjacent the primary opening and pulling the plug into the fistula tract through the primary opening, whereby wedging the first end of the plug into the primary opening; and
said securing includes securing an end of the plug adjacent the primary opening to tissue of the patient.
13. The method of claim 11 , wherein the securing comprises the application of an adhesive.
14. The method of claim 11 , the bioremodelable material comprises an intact acellular sheet of dermal collagen or submucosa.
15. The method of claim 11 , wherein the securing an end of the plug to tissue of the patient comprises suturing an end of the plug to tissue of the patient adjacent the primary opening or the secondary opening.
16. The method of claim 11 , wherein the bioremodelable material incorporates a drug.
17. A method for treating a fistula of a patient, the fistula having a tract extending from a primary opening in a first body lumen to a secondary opening in a second body lumen, the method comprising:
implanting a plug in the fistula tract so as to occlude the primary opening, the plug having a plug body, wherein the plug body is tapered and comprises bioremodelable material selected from the group consisting of a cadaveric material from a human donor and a heterograft material from a non-human donor, wherein the bioremodelable material extends along the fistula tract from the primary opening to the secondary opening of the fistula; and
securing the plug to tissue of the patient, wherein the securing comprises the application of an adhesive, and
cutting a portion of the plug body extending from at least one of the primary opening and the secondary opening of the fistula.
18. The method of claim 17 , wherein the bioremodelable material comprises an intact, acellular sheet of dermal collagen or submucosa.
19. The method of claim 17 , wherein the securing an end of the plug to tissue of the patient comprises suturing an end of the plug to tissue of the patient, wherein said end is adjacent the primary opening or the secondary opening.
20. The method of claim 17 , wherein the bioremodelable material incorporates a drug.